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Abstract: The present article describes the isolation of a new natural product of the lobophorin
family, designated as lobophorin K (1), from cultures of the marine actinobacteria Streptomyces sp.
M-207, previously isolated from the cold-water coral Lophelia pertusa collected at 1800 m depth during
an expedition to the submarine Avilés Canyon. Its structure was determined using a combination
of spectroscopic techniques, mainly ESI-TOF MS and 1D and 2D NMR. This new natural product
displayed cytotoxic activity against two human tumor cell lines, such as pancreatic carcinoma
(MiaPaca-2) and breast adenocarcinoma (MCF-7). Lobophorin K also displayed moderate and
selective antibiotic activity against pathogenic Gram-positive bacteria such as Staphylococcus aureus.
Keywords: lobophorins; spirotetronate antibiotic; Streptomyces; antitumor; Cantabrian
Sea-derived actinobacteria
1. Introduction
Lobophorins are natural products of marine origin with pharmacological interest due to their
diverse biological activities. Structurally, they are members of the spirotetronate family first reported
as anti-inflammatory compounds, such as lobophorins A and B [1]. Antibiotic activities were
subsequently reported for other members of the family, such as lobophorins E and F [2], lobophorin
G [3], and lobophorins H and I [4,5]. Unfortunately, due to an overlapping in the publication dates,
the two last references add some confusion to the nomenclature of the lobophorin family, as the names
lobophorin H and I were assigned twice to new compounds whose structures are not coincident,
isolated independently by both research groups. The compound named lobophorin I in the Lin
paper [5] has the same structure as lobophorin H in the Pan article [4], and the compound whose
name was assigned as lobophorin H in the Lin paper would represent a new natural product whose
name should be perhaps be reassigned as lobophorin I* in order to not add more confusion to the
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nomenclature of these molecules, taking into account the publication date of both articles. Very recently,
three additional members of the lobophorin family—namely lobophorins CR1, CR2, and CR3 were
isolated from cultures of Streptomyces sp. strain 7790N4 [6]. Finally, the isolation of a compound
named lobophorin J from a culture of the deep sea-derived Streptomyces sp. strain 12A35 has also been
reported [7]. In addition to their antimicrobial activities, some lobophorins also display cytototoxic
activity against different tumor cell lines, such as lobophorins C and D against liver and breast tumor
cell lines [8], lobophorin F against SNC, breast, and lung tumor cell lines [2], and lobophorins CR1 and
CR2 against oral cancer cell lines [6].
Previous research in the Cantabrian Sea (Biscay Bay), Northeast Atlantic, has revealed that
bioactive actinobacteria, mainly Streptomyces species, are associated to corals and other invertebrates
living up to 4700 m depth in the submarine Avilés Canyon [9–11]. Recently, actinobacteria displaying
a wide repertoire of chemically diverse secondary metabolites with different antibiotic or antitumor
activities have been isolated from coral reef ecosystems from the Avilés Canyon [12]. We report here the
finding of a new natural product, lobophorin K, obtained from Streptomyces sp. M-207, isolated from
the cold-water coral Lophelia pertusa collected at 1800 m depth in this submarine canyon. Following our
LC-UV-MS and LC-HRMS chemical dereplication approaches for marine natural products [13], it was
determined that the extract obtained from fermentation broths of this strain contained lobophorins A
and B, together with a new member of the lobophorin family. After targeted isolation, we have shown
that this new compound, lobophorin K, displays cytotoxic activities against two human tumor cell
lines, particularly pancreatic carcinoma and breast adenocarcinoma and it also presents moderate and
selective antibiotic activity against pathogenic Gram-positive bacteria such as S. aureus.
2. Results
2.1. Taxonomy and Phylogenetic Analysis of the Strain M-207
The 16S rDNA of producing strain M-207 was amplified by polymerase chain reaction (PCR) and
sequenced [12]. After Basic Logic Alignment Search Tool (BLAST) sequence comparison strain M-207
showed 99.89% (920/921) identities to Streptomyces carnosus NBRC 13025T, Streptomyces olivaceus NRRL
B-3009T, and Stresptomyces pactum NBRC 13433T. The phylogenetic tree generated by a neighbor-joining
method based on 16S rDNA sequence clearly revealed the evolutionary relationship of the strain M-207
with these three known Streptomyces species (Figure 1). So, in the absence of further taxonomic analysis
the strain was designated as Streptomyces sp. M-207.
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2.2. Structure Determination 
Compound 1 had a molecular formula of C61H92N2O20 according to the protonated  ion at m/z 
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2.2. Structure Determination
Compound 1 had a molecular formula of C61H92N2O20 according to the protonated ion at
m/z 1173.6322 observed in its ESI-TOF spectrum (calc. for C61H93N2O20+, 1173.6316, ∆ 0.5 ppm).
Signals observed in its 1H and 13C NMR spectra (Table 1) and correlations observed in the 2D
NMR spectra were indicative of a lobophorin-like structure for the compound. The molecule had
an additional oxygen atom compared with lobophorin A, and the major differences between the
spectra of this new compound and those of this molecule and other lobophorins were found around
the deoxyaminosugar moiety attached to carbon C17 (unit D). In most of the compounds of the
lobophorin series, an amino (–NH2) or a nitro (–NO2) substituent is found at position D3. Interestingly,
the new lobophorin bears a hydroxylamino (–NHOH) substituent at that position. This indeed
represents an intermediate oxidation state between the amino and nitro functional groups found
in the lobophorin series at position D3. Such an intermediate oxidation state would represent and
intermediate biosynthetic product among both types of lobophorins. For lobophorin H and lobophorin
I (according to [5]), carrying respectively amino and nitro substitution at position D3, NMR data have
been reported in CD3OD, allowing a direct comparison of the chemical shifts observed for ring D
with those of the new lobophorin herein reported. Such comparison revealed the expected differences,
especially in the resonance frequency of carbon at position D3, which is found at 61.6 ppm in the new
lobophorin and at 57.0 and 92.9 ppm in lobophorins H and I respectively. The carbon chemical shift
measured at position D3 for the new lobophorin is in agreement with the expected deshielding for the
hydroxylamino functionality (61.6 ppm) with respect to the amino functionality (57.0 ppm), though
it is strongly shielded compared to the nitro functionality (61.6 ppm vs. 92.9 ppm). Compound 1
therefore had the structure depicted in Figure 2, being the hydroxylamino derivative of lobophorin A.
Table 1. 1H and 13C NMR (500 and 125 MHz in CD3OD) data for compound 1.
Position δ 1H (mult, J, Hz) ∆ 13C Position δ 1H (mult, J, Hz) δ 13C
1 - n.d. - - -
2 - 100.7 A1 4.77 (br d, 4.1) 99.7
3 - 205.0 a A2 2.39 (m), 1.74 (m) 31.0
4 - 52.4 A3 4.02 (dd, 6.1, 2.9) 69.3
5 2.08 (m) 44.8 A4 3.26 (dd, 9.6, 3.3) 73.4
6 1.61 (m) 32.5 A5 4.10 (m) 66.0
7 1.61 (m), 1.53 (m) 43.0 A6 1.21 (d, 6.4) 18.2
8 2.24 (m) 35.9 - - -
9 3.42 (dd, 10.1, 5.3) 86.2 B1 5.17 (br d, 3.5) 93.2
10 2.09 (m) 39.7 B2 2.09 (m), 1.99 (dt, 14.6, 3.7) 35.9
11 5.81 (br d, 10.2) 127.2 B3 4.18 (dd, 6.5, 3.5) 68.1
12 5.38 (ddd, 10.2, 4.9, 1.8) 127.9 B4 3.29 (m) 83.3
13 3.65 (m) 52.7 B5 4.06 (m) 63.7
14 - 137.1 B6 1.21 (d, 6.3) 18.0
15 5.20 (brd, 9.4) 124.9 - - -
16 2.40 (m), 2.26 (m) 32.5 C1 4.95 (dd, 9.7, 1.7) 100.7
17 4.20 (m) 80.3 C2 2.05 (m), 1.72 (m) 38.8
18 - 139.3 C3 4.29 (dd, 5.8, 2.8) 64.4
19 5.12 (br d 10.5) 120.2 C4 2.85 (dd, 9.4, 2.8) 83.8
20 3.59 (br d, 10.4) 41.5 C5 3.81 (dq, 9.4, 6.2) 69.6
21 5.43 (br s) 122.7 C6 1.23 (d, 6.3) 18.6
22 - 142.5 C7 3.38 (s) 57.0
23 2.62 (m) 29.0 - - -
24 2.39 (m), 1.79 (d, 14.2) 36.4 D1 4.73 (dd, 9.8, 2.5) 99.2
25 - 84.9 D2 1.61 (m), 1.50 (dd, 14.3, 9.8) 37.5
26 - 200.9 D3 - 61.6
27 1.55 (s) 15.5 D4 3.66 (m) 54.1
28 0.65 (br d, 4.2) 22.9 D5 4.23 (qd, 6.4, 1.6) 69.4
29 1.14 (d, 7.0) 14.8 D6 1.08 (d, 6.4) 17.5
30 1.38 (br s) 14.2 D7 1.15 (s) 22.6
31 1.41 (br s) 15.3 D8 - 160.1
32 4.14 (br s), 4.09 (m) 65.0 D9 3.65 (s) 52.4
33 1.28 (d, 7.2) 20.5 - - -
n.d. = not detected; a detected via HMBC.
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2.3. Antimicrobial Activity of Lobophorin K
In order to determine the antibiotic properties of the molecule, it was tested against a panel
of Gram-positive and Gram-negative clinical pathogens. As shown in Table 2, it did not exhibit
remarkable antibacterial activities against Gram-negative bacteria such as Pseudomonas aeruginosa,
Acinetobacter baumannii, Klebsiella pneumoniae, or Escherichia coli. However, lobophorin K displayed
moderate and selective activity against Gram-positive bacteria such as methicillin sensitive S. aureus
EPI167, with a MIC90 value of 40–80 µg/mL.
able 2. I 90 values of co pound 1 against ra -positive and ra -negative bacteria.
Bacteria Lobophorin K (MIC90 µg/mL)
Gram-positive -
Staphylococcus aureus EPI1167 MSSA 40–80
Staphylococcus aureus MB5393 MRSA >160
Gram-negative -
Acinetobacter baumannii MB5973 >160
Pseudomonas aeruginosa PAO1 >160
Klebsiella pneumoniae ATCC 700603 >160
Escherichia coli MB2884 >160
2.4. Cytotoxic Activity of Lobophorin K
The compound sh wed cyt toxic activity with IC50 values of 23.0± 8.9, 34.0± 85.1, and 6.3 ± 8.2 µM
against a human breast adenocarcinoma cell line (MCF-7), a human pancreatic carcinoma cell line
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(MiaPaca-2), and a human immortalized hepatocyte cell line (THLE-2), respectively (Figure S9).
Lobophorin K was inactive at the maximum concentration tested (42.6 µM) against other human tumor
cell lines such as lung (A-549), colon (HT-29), and hepatocarcinoma (HepG2).
3. Experimental Section
3.1. General Experimental Procedures
All solvents were purchased from VWR Chemicals (Barcelona, Spain). Analytical and
semi-preparative HPLC was conducted using a Waters Alliance chromatographic system (Waters
Corporation, Mildford, MA, USA) with a SunFire C18 column (10 µm, 10× 250 mm, Waters). For UPLC
analysis, an Acquity UPLC equipment (Waters) with a BEH C18 column (1.7 µm, 2.1 × 100 mm,
Waters) was used. Optical rotations were determined with a JASCO P-2000 polarimeter (JASCO
Corporation, Tokyo, Japan). IR spectrum was measured with a JASCO FT/IR-4100 spectrometer
(JASCO Corporation) equipped with a PIKE MIRacleTM single reflection ATR accessory. NMR spectra
were recorded on a Bruker Advance III spectrometer (500 and 125 MHz for 1H and 13C NMR,
respectively) equipped with a 1.7 mm TCI MicroCryoProbeTM (Bruker Biospin, Fällanden, Switzerland),
using the signal of the residual solvent as internal reference (δH 3.31 and δC 49.0 ppm for CD3OD).
ESI-TOF MS spectra were acquired using a Bruker maXis QTOF spectrometer (Bruker Daltonik GmbH,
Bremen, Germany).
3.2. Phylogenetic Analysis of the Producing Microorganism
Strain Streptomyces sp. M-207 was subjected to phylogenetic analysis based on 16S rDNA sequence
analysis [12]. Phylogenetic analysis was performed using MEGA version 6.0 [14] after multiple
alignment of data by Clustal Omega [15]. Distances were calculated using distance options according
to the Kimura two-parameter model [16]. Clusters constricted by the neighbor-joining method [17]
were evaluated using bootstrap values based on 1000 replications [18].
3.3. Microorganism and Fermentation Conditions
Strain M-207 was isolated from a deep-sea coral sample collected from the Cantabrian Sea at
the depth of 1800 m [12]. 30 Erlenmeyer flasks (250 mL), each containing 50 mL of R5A medium,
as previously described [9] were inoculated with spores and incubated in an orbital shaker at 28 ◦C
and 250 rpm for four days.
3.4. Isolation and Purification of Lobophorin K
The cultures were centrifuged and pellets and supernatants were processed separately. The pellets
were extracted twice with ethyl acetate acidified with 1% formic acid. The supernatants were filtered
and applied to a solid-phase extraction cartridge (Sep-Pak Vac C18, 10 g, Waters). The retained material
was eluted with a mixture of methanol and 0.05% TFA in water. A linear gradient from 0 to 100%
methanol in 60 min, at 10 mL/min, was used. Fractions were taken every 5 min and analyzed by
UPLC using chromatographic conditions previously described [19]. A peak corresponding to the
unknown lobophorin was observed in fractions taken between 45 and 55 min. These fractions were
pooled, dried in vacuo, and the residue was subsequently re-dissolved in a small volume of DMSO and
methanol (1:1). The same peak was also found in the organic extract of the culture pellets, which was
processed in the same way. The desired compound was purified by semi-preparative HPLC using a
SunFire C18 column (10 µm, 10 × 250 mm, Waters). The mobile phase was a mixture of acetonitrile
and 0.05% TFA in water in isocratic conditions, at 7 mL/min. The purification was performed in two
steps, with 90% acetonitrile in the first step and 50% in the second step. In both cases, the solution
containing the collected peak was partially evaporated under vacuum to reduce the concentration
of the organic solvent and then applied to a solid-phase extraction cartridge (Sep-Pak C18, Waters).
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The cartridge was washed with water, the retained compound was eluted with methanol and finally
lyophilized, resulting in 1.9 mg of pure compound 1.
Lobophorin K (1): yellowish amorphous solid; [α]20D −102.2 (c 0.1, MeOH); IR (ATR) υmax 3427,
2931, 1708, 1630, 1549, 1454, 1412, 1378, 1126, 1095, 1060, 1013, 926, 868 cm−1; for 1H and 13C NMR
data see Table 1; HRESIMS m/z 1173.6322 [M + H]+ (calcd. for C61H93N2O20+, 1173.6316), 1195.6141
[M + Na]+ (calcd. for C61H92N2O20Na+, 1195.6136).
3.5. Antimicrobial Activity of Lobophorin K
Previously described methods, using pathogenic strains from Fundación MEDINA’s collection
were used to test for antibiotic properties [20]. Briefly, the compound was serially diluted in DMSO
with a dilution factor of 2 to provide 10 concentrations for all the assays. The MIC was defined as
the lowest concentration of compound that inhibited ≥90% of the growth of a microorganism after
overnight incubation. Genedata Screener software (Genedata, Inc., Basel, Switzerland) was used to
analyze the data and to calculate the RZ’ factor to estimate the robustness of the assays [21]. In all
experiments performed in this work, the RZ’ factor obtained was between 0.85 and 0.92. The compound
was tested in two different days and in triplicate at final assay concentrations ranging between 160
and 0.31 µg/mL.
3.6. Cytotoxic Activity of Lobophorin K
Five tumor cell lines (MCF-7, MiaPaca-2, HepG2, A-549, and HT-29) and one non-tumor cell line
(THLE-2) were obtained from ATCC. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) colorimetric assay, which measures mitochondrial metabolic activity, was employed to
estimate the amount of living cells. Ten thousand cells per well (for 72 h assay) were plated in
96-well plates with a cell culture robotic system, SelecT (TAP Biosystems, Royston, UK). After 24 h of
incubation, lobophorin K and solvent as blank were added with the automated liquid-handling system
Biomek FX (Beckman Coulter, Pasadena, CA, USA), and plates were incubated for 72 h. The test
compound was examined in triplicate with serial two-fold dilutions. After incubation, MTT was added
and plates were gently shaken and incubated for 3 h at 37 ◦C in 5% CO2 incubator. The supernatant
was removed and 100 mL of DMSO 100% was added. The plates were gently shaken to solubilize the
originated formazan and absorbance at 570 nm was read in a Victor2 Wallac spectrofluorometer (Perkin
Elmer, Waltham, MA, USA). IC50 values were calculated as the concentration that decreases 50% of
the cell viability using Genedata Screener software (Genedata AG, Basel, Switzerland). Curve fitting
followed the Smart Fit strategy with Hill model selection.
4. Conclusions
In summary, a new member of the lobophorin family that we have designated as lobophorin K has
been obtained from cultures of Streptomyces sp. M-207, previously isolated from the cold-water coral
Lophelia pertusa collected at 1800 m. Its structure was determined using a combination of spectroscopic
techniques, mainly ESI-TOF MS and 1D and 2D NMR, and comparison with the NMR spectra of
other members of the family. This new natural product displayed cytotoxic activity human pancreatic
carcinoma (MiaPaca-2) and breast adenocarcinoma (MCF-7) human cells as well as moderate and
selective antibiotic activity against pathogenic Gram-positive bacteria such as Staphylococcus aureus.
The research described herein confirms once more that marine derived actinomycetes continue to
be a rich and underexploited source of new small molecules that could lead to the discovery of new
antibiotics and anticancer drugs.
Supplementary Materials: The following are available online at www.mdpi.com/1660-3397/15/5/144/s1,
Figure S1: UV spectrum of compound 1; Figure S2: ESI-TOF spectra of compound 1; Figure S3: 1H NMR
spectrum (CD3OD, 500 MHz) of compound 1; Figure S4: 13C NMR spectrum (CD3OD, 125 MHz) of compound 1;
Figure S5: COSY spectrum of compound 1; Figure S6: HSQC spectrum of compound 1; Figure S7: HMBC spectrum
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of compound 1; Figure S8: ROESY spectrum of compound 1; Figure S9: Dose response curves of compound 1
against MCF-7, MiaPaca-2 and THLE-2 human cell lines.
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